The detailed chemical description of abacavir sulfate, identified by the CAS number 188062-50-2, demonstrates it is a synthetic guanine analog used as an reverse transcriptase inhibiting agent. Structurally, it exists as a sulfate salt, contributing to enhanced dissolvability compared to the free base. Its molecular APIXABAN 503612-47-3 formula is C14H15N6O4S and exhibits a molecular of approximately 385.41 grams per mole. Furthermore, abacavir sulfate operates by inhibiting retroviral reverse transcriptase, a essential enzyme for HIV replication.
```text
Abarelix (183552-38-7): Attributes, Uses , and Security
Abarelix, identified by the CAS number 183552-38-7 , is a laboratory-created protein designed primarily for the treatment of prostatic growth (BPH). Its key characteristics include being a extremely specific activator of GnRH receptors. Medically, it’s employed to suppress male hormone levels and as a result reduce the aden and its related indicators . With respect to safety , while generally accepted , abarelix can cause undesirable effects , including injection site reactions , flushing , and conceivably severe cardiovascular occurrences . Therefore, careful individual assessment and correct dosing are essential . Further research continues to investigate its full medical potential and optimize its harmlessness history.
```
Abiraterone Acetate (154229-18-2): Synthesis and Pharmaceutical Relevance
Abiraterone salt substance, a potent antagonist of testosterone generation, has emerged as a critical pharmaceutical medication in the therapy of advanced prostate cancer . Distinct synthetic routes have been developed for its manufacture , often utilizing complex chemical processes . Key approaches include pyridin- ring construction and following hormonal structure modification . The obtained abiraterone acetate is then changed to a clinically acceptable form. The therapeutic significance stems from its power to reduce testosterone levels, thereby decreasing cancer cell proliferation and enhancing patient prognosis . Further study continues to investigate innovative laboratory procedures and potential applications of this important healing compound .
- Various synthetic processes have been described.
- Substance acts as an inhibitor .
Understanding Abacavir Sulfate: CAS 188062-50-2 Explained
Abacavir the sulfate, identified by its Chemical Abstracts Service (CAS) Registry Number 188062-50-2, constitutes a significant antiretroviral medication employed in the management of HIV disease. Such compound functions as a nucleoside reverse transcriptase blocker, effectively stopping the pathogen from spreading within the body. Understanding its properties and function is critical for clinical professionals and individuals receiving this recommended therapy; besides, genetic screening is needed prior to commencement of abacavir administration to determine likelihood of a hypersensitivity response.
Examining CAS Identifier Breakdown: Exploring This Compound (183552-38-7)
The Unique Designation 183552-38-7 is associated with abarelix, a decapeptide used primarily in treating prostate conditions. Its precise identifier facilitates accurate recognition of this particular molecule within research databases and literature . Abarelix functions by blocking gonadotropin-releasing hormone (GnRH), significantly suppressing male hormones synthesis. Additional information regarding the compound's features, safety information and clinical applications can be accessed using this official registry number .
- Peptide Structure
- Biological Activity
- Legal Status
Abiraterone Acetate (154229-18-2): Chemical Data and Therapeutic Uses
Zytiga salt (CAS Registry Number 154229-18-2) represents a engineered hormone blocker of male hormone formation. Chemically, it's described as (3β)-hydroxy-21cyclic-piperidine-5androstane form, and its structural formula is C26H30O3. Its primary clinical application is in the management of metastatic gland cancer, often in association with copyright medication. Research indicate it effectively decreases testosterone levels in patients, resulting to enhanced outcomes. The drug works by preventing the protein 17α-hydroxylase/C17,20-lyase, which is important for androgen creation within the suprarenal organs and testes.